Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-01-02
2007-01-02
Berch, Mark (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C540S552000, C540S542000, C540S362000, C540S524000, C514S211100, C514S230500, C544S105000, C544S003000
Reexamination Certificate
active
11288533
ABSTRACT:
The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV
REFERENCES:
patent: 2004/0006065 (2004-01-01), Glunz
patent: WO 2003/035076 (2003-05-01), None
patent: WO 2003/035077 (2003-05-01), None
patent: WO 2004/058756 (2004-07-01), None
patent: WO 2004/058757 (2004-07-01), None
patent: WO 2005/061490 (2005-07-01), None
patent: WO 2005/061501 (2005-07-01), None
U.S. Appl. No. 10/755,642, filed Jan. 12, 2004, Michael A. Walker et al.
Banville Jacques
Beaulieu Francis
Connolly Timothy P.
Krystal Mark R.
Matiskella John D.
Berch Mark
Bristol--Myers Squibb Company
Epperson James
Moore Susanna
LandOfFree
Bicyclic heterocycles as HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic heterocycles as HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heterocycles as HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3729578